Roche acquires Signature Diagnostics

11-Feb-2015 - Roche announced the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are ...

Signature Diagnostics Receives Extended Patent Protection for its Proteasome-Complex Inhibitors

09-Dec-2010 - Signature Diagnostics AG announced that the European Patent Office (EPO) has granted a new patent providing extended protection for drug molecules licensed by the company from the Technical University of Darmstadt. The new patent (EP 1858913) covers peptide-mimetics and their use as inhibitors of ...

Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board

05-Oct-2010 - Signature Diagnostics AG announced the appointment of Rainer Kramer as Chief Business Officer. Dr. Kramer previously held the position of Vice President Corporate Business Development at Jerini AG, where he was responsible for all licensing, partnering, and alliance management activities. ...

Signature Diagnostics Presents Positive Colorectal Screening Study Results

12-Jul-2010 - Signature Diagnostics announced that on June 30 2010, company CEO, Andre Rosenthal presented the positive results of its colorectal cancer screening test. Detector C, an in-vitro diagnostic blood-based screening product for the early detection of colorectal cancer, has been shown to detect 90% of ...

Signature Diagnostics Announces Positive Study Results Using Predictor C to Predict Colorectal Cancer Progression

07-Jun-2010 - Signature Diagnostics AG announced positive results from its international, prospective, multi-center performance evaluation study showing the diagnostic ability of Predictor C to distinguish between high-risk and low-risk disease progression. Predictor C, a prognostic tissue test for UICC stage ...

OncoMethylome Sciences SA to Initiate a Large Colorectal Cancer Clinical Trial

OncoMethylome Sciences to Acquire Minority Interest in Signature Diagnostics AG

31-Jan-2008 - OncoMethylome Sciences announced that it plans to launch a large, international, multi-center colorectal cancer clinical trial. The German portion of the international trial will be managed by Signatures Diagnostics. Signature Diagnostics will receive an upfront payment plus service fees for its ...